WPW
KRRO icon

Waldron Private Wealth’s Korro Bio KRRO Stock Holding History

Waldron Private Wealth’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,413
Closed -$26.1K – 427
2023
Q3 		$26.1K Hold
1,413
– – ﹤0.01% 370
2023
Q2 		$24.5K Hold
1,413
– – ﹤0.01% 371
2023
Q1 		$35.5K Hold
1,413
– – ﹤0.01% 410
2022
Q4 		$126K Hold
1,413
– – 0.01% 356
2022
Q3 		$126K Hold
1,413
– – 0.01% 359
2022
Q2 		$106K Buy
+1,413
New +$95.5K 0.01% 368

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Waldron Private Wealth's KRRO Position: Q4 2023 in Review

Waldron Private Wealth sold out of Korro Bio (KRRO) in Q4 2023, closing a stake of 1,413 shares — an estimated $26.1K sold.

Waldron Private Wealth first reported a position in KRRO in Q2 2022 and held it in 6 quarters. The position peaked at $126K in Q4 2022. 40 funds tracked by Wall St. Rank hold KRRO as of Q4 2023.

  • Waldron Private Wealth reported no remaining Korro Bio position as of Q4 2023 after selling out during the quarter.
  • Waldron Private Wealth sold 1,413 Korro Bio shares in Q4 2023, an estimated $26.1K.
  • Waldron Private Wealth first reported a position in Korro Bio in Q2 2022 and held it in 6 quarters.
  • Waldron Private Wealth's Korro Bio position peaked at $126K in Q4 2022.
  • 40 funds tracked by Wall St. Rank held Korro Bio as of Q4 2023.

Based on Waldron Private Wealth's 13F filing for Q4 2023, filed 30 Jan 2024.